cancer clinical trials for Gyn/Onc (OB/GYNONC)
11 Gyn/Onc (OB/GYNONC) clinical trials found. View a list of all cancer clinical trial types.
-
A Randomized Phase III Trial of Carboplatin, Paclitaxel, Pembrolizumab Versus Carboplatin, Paclitaxel, Bevacizumab Versus Carboplatin, Paclitaxel, Pembrolizumab, Bevacizumab in the Treatment of pMMR, TP53 Mutated Advanced or Recurrent Endometrial Cancer
Current Status: Open
View links and contact information related to this clinical trial -
A Phase III, Randomized, Open-label, Multicenter Study of Sacituzumab Tirumotecan (sac-TMT, MK-2870) Maintenance Treatment With or Without Bevacizumab Versus Standard of Care in Participants With Newly Diagnosed Advanced non-HRD positive Ovarian Cancer Following First-line Platinum- based Chemotherapy (TroFuse-021/ENGOTov85/GOG-3102)
Current Status: Open
View links and contact information related to this clinical trial -
A Phase III Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) Versus Treatment of Investigator's Choice (IC) in Patients With Platinum Resistant Ovarian Cancer
Current Status: Open
View links and contact information related to this clinical trial -
A Phase III Trial of One vs. Two Years of Maintenance Olaparib, With or Without Bevacizumab, in Patients With BRCA1/2 Mutated or Homologous Recombination Deficient (HRD+) Ovarian Cancer Following Response to First Line Platinum-Based Chemotherapy
Current Status: Open
View links and contact information related to this clinical trial -
A Phase I/II, Open-Label, Dose-Escalation and Expansion First-In-Human Study of ATX-295, an Oral Inhibitor of the Kinesin Motor Protein KIF18A, in Patients With Locally Advanced or Metastatic Solid Tumors, Including High-Grade Serous Ovarian Cancer
Current Status: Open
View links and contact information related to this clinical trial -
A Phase I First-in-Human, Open-Label Study Evaluating Safety, Pharmacokinetics, and Efficacy of ABBV-901 as a Monotherapy and in Combination With Bevacizumab in Adult Subjects With Ovarian Cancer
Current Status: Open
View links and contact information related to this clinical trial -
A Phase I First-in-Human Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors
Current Status: Open
View links and contact information related to this clinical trial -
A Non-Randomized Prospective Clinical Trial Comparint the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers (SOROCk)
Current Status: Open
View links and contact information related to this clinical trial -
NRG-GY037: A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab Versus Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer
Current Status: Open
View links and contact information related to this clinical trial -
The ROSE Study - Research On Survivorship Experiences. Disparities in cancer-related outcomes between rural and non-rural cancer survivors in the catchment areas of the Big 10 Cancer Research Consortium's Population Science Working Group
Current Status: Open
View links and contact information related to this clinical trial -
Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Current Status: Open
View links and contact information related to this clinical trial